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Delayed Diagnosis 
of Dirofilariasis and 
Complex Ocular 
Surgery, Russia
To the Editor: Dirofilaria repens 
is a vector-borne, zoonotic, filarial 
nematode that infects dogs, cats, and 
humans. In humans, D. repens worms 
cause subcutaneous dirofilariasis, char-
acterized by the development of benign 
subcutaneous nodules that mimic skin 
carcinomas (1), and ocular dirofilaria-
sis in orbital, eyelid, conjunctival, ret-
roocular, and intraocular locations (2). 
Intraocular and retroocular dirofila-
riasis causes considerable damage and 
discomfort in patients from the pres-
ence of the worms and from their surgi-
cal removal (3). Here, we report a ret-
roocular D. repens nematode infection 
in a patient in Russia that illustrates 
the difficulties in clinical management 
and the inherent risks of surgical proce-
dures to remove the worms.
A 20-year-old woman living in 
Rostov-na-Donu in southwestern Rus-
sia who had never traveled outside the 
city sought ophthalmologic consul-
tation for pain and skin redness and 
swelling in the inner corner of the 
upper left eyelid. Swelling migrated 
successively to the temporal area, the 
lower eyelid, and the inner corner of 
the lower eyelid. The patient had no 
other ocular signs or symptoms, and 
her general condition was otherwise 
good. Results of ophthalmologic ex-
amination and routine laboratory tests 
were within normal limits. Four days 
of treatment with cefotaxime resulted 
in the remission of signs and symp-
toms. Approximately 2 months later, 
swelling in the inner corner of the 
upper eyelid appeared again, affect-
ing the whole upper eyelid, without 
itching or tenderness. Allergies were 
diagnosed; cetirizine was adminis-
tered for 4 days, and the signs remit-
ted at the third day of treatment. One 
month later, marked upper left eyelid 
swelling occurred, resulting in ptosis. 
Cetirizine was prescribed again; ede-
ma subsided after 4 days of treatment 
but relapsed in the following 3–4 days. 
At least 4 subsequent relapses oc-
curred; thus, a computed tomographic 
scan of the paranasal sinuses and or-
bits was performed, 4 months after 
signs and symptoms began (Figure, 
panel A). The scan detected a soft tis-
sue structure, 12 × 13 × 14 mm, be-
hind the left eyeball, adjacent to and 
medially dislodging the optic nerve. 
No other abnormalities were found 
in the visible area of the brain and 
sinuses. Magnetic resonance imag-
ing (MRI) performed 1 month later 
(Figure, panel B) corroborated the 
presence of a cyst-like structure with 
an irregular, rounded shape and clear, 
smooth borders closely adhered to the 
eyeball and optic nerve. T2-weighted 
images showed that the lesion had a 
high-density core but the surrounding 
tissue was low density. Adjacent to 
the lesion, the retrobulbar tissue was 
slightly swollen, the optic nerve was 
displaced medially and downward, 
and the adjacent upper muscle was 
displaced medially and upward. The 
diagnosis was evidence of a retroocu-
lar cystic lesion in the left orbit with a 
well-defined capsule and high-density 
but heterogeneous core structure. 
High-resolution ultrasound ex-
amination (Figure, panel C) revealed 
a well-defined, 3-mm, cyst-like wall 
containing fluid and dense, coiled-
twisted linear internal structures that 
appeared to be actively moving (Vid-
eo 1, Appendix, wwwnc.cdc.gov/EID/
article/19/2/12-1388-V1.htm). Color 
Doppler examination (Figure, panel 
D; Video 2, Appendix, wwwnc.cdc.
gov/EID/article/19/2/12-1388-V2.
htm) revealed blood vessels in the 
wall but not inside the cystic structure. 
These additional examinations led to 
a diagnosis of a retroocular parasitic 
cyst in the left orbit, most likely a Di-
rofilaria spp. parasite. The parasitic 
cystic nodule was removed during 
a transpalpebral orbitotomy. A live, 
adult roundworm, 87 × 0.6 mm, was 
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discharged from the cyst. Conven-
tional PCR identified the roundworm 
as D. repens (data not shown).
Although human subcutaneous 
Dirofilaria spp. nodules are benign, 
their detection may raise suspicion for 
a malignant tumor; thus, differential 
diagnosis is the key point in the man-
agement of human dirofilariasis (4). 
The case we described illustrates the 
difficulties of diagnosis when worms 
are in deep locations and patients ex-
perience unspecific and even unusual 
signs. These confounders resulted in 
a lengthy diagnostic procedure, with 
consequent detrimental physical and 
psychological effects on the patient. 
Even though the final diagnosis de-
termined that the nodule was nonma-
lignant, its anatomic location required 
aggressive surgical intervention to re-
move it.
D. repens nematodes are spread-
ing in Europe from the south toward 
the north and east (5–7) as a conse-
quence of global warming, and predic-
tion models have suggested incidence 
is increasing among animal and hu-
man hosts (3). Consequently, human 
ocular dirofilariasis will probably be 
found with increasing frequency in the 
future. Our experience illustrates that 
dirofilariasis should be included in the 
differential diagnosis of any nodule, 
independent of its anatomic location 
and the signs and symptoms shown 
by the patient. Moreover, ultrasonog-
raphy represents a noninvasive tech-
nique that enables rapid preoperative 
identification of the parasitic origin of 
the nodules, thus avoiding unneces-
sary diagnostic delays. This technique 
is used for the diagnosis of cardiopul-
monary dirofilariasis in animals (8) 
but has been used only sporadically 
for human dirofilariasis (9,10), which 
is habitually diagnosed postopera-
tively, after the surgical removal of the 
nodules or worms (1).
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To the Editor: Lymphocytic 
choriomeningitis virus (LCMV) 
is a rodent-borne pathogen that 
causes a spectrum of disease in 
humans, ranging from self-limiting 
meningoencephalitis to congenital 
birth defects to severe disseminated 
illness in organ transplant recipients 
(1). It is not known how frequently 
cases of LCMV infection are 
diagnosed in the United States. 
We performed a retrospective case 
analysis of American Indian and 
Alaska Native (AI/AN) patients treated 
within the Indian Health Service 
(IHS) health care system who had an 
LCMV-associated diagnosis defined 
by the International Classification 
of Diseases, 9th Revision, Clinical 
Modification (ICD-9-CM). Our goal 
was to estimate the incidence of 
LCMV-associated aseptic meningitis 
and encephalitis diagnosed within a 
well-defined population.
Inpatient and outpatient visit 
data from fiscal years 2001–09 were 
obtained from the IHS National 
Patient Information Reporting System 
(2). For each fiscal year, records 
for AI/AN patients with at least 1 
inpatient or outpatient visit within the 
year that listed the ICD-9-CM code 
049.0 (lymphocytic choriomeningitis 
and meningoencephalitis) were 
selected (3,4). A subset of medical 
records was reviewed for patients with 
the diagnosis code of interest in the 
IHS Southwest and Southern Plains 
regions. Health care facilities were 
located in Arizona, New Mexico, and 
Oklahoma, USA. Suspected LCMV 
infection was defined as a diagnosis 
of meningitis, choriomeningitis, 
encephalitis, or meningoencephalitis 
not explained by another etiologic 
agent. A confirmed case of LCMV 
infection required laboratory detection 
of antibodies, virus antigen, or virus. A 
patient with no evidence of suspected 
LCMV infection in his or her  medical 
record was not considered to have a 
case of LCMV infection.
Annual population denominators 
were determined by using annual IHS 
Southwest and Southern Plains region 
user populations, which includes all 
registered AI/ANs who received IHS-
funded health care at least once during 
the previous 3 years (5). The annual 
average incidence rate for diagnosed 
cases of infection with LCMV was 
determined. Rates were also determined 
for viral meningitis not otherwise 
specified (ICD-9-CM code 047.9); 
for unspecified causes of encephalitis, 
myelitis, or encephalomyelitis (323.9); 
and for unspecified non-arthropod–
borne viral diseases of the central 
nervous system or viral encephalitis 
not otherwise specified (049.9) (3). 
Annual numbers were calculated on a 
patient basis, whereby the first time a 
diagnosis was coded for a given patient 
during each fiscal year was counted.
Twenty-six AI/AN patients 
received the diagnosis code of 049.0 
during fiscal years 2001–09. Of these 
patients, 16 received the diagnosis in the 
Southwest or Southern Plains regions. 
Fourteen available medical charts from 
these 2 regions were reviewed, and 
4 patients were classified as having 
signs and symptoms consistent with 
suspected LCMV infection (Table), 
although no patients were confirmed 
by diagnostic testing as having LCMV 
infection. All 4 suspected cases of 
LCMV infection were in women (age 
range 16–43 years) who had a 1–2-
day history of headache, nausea, and 
vomiting. Photophobia and neck or 
back pain were present in patients 1–3. 
Cerebrospinal fluid from patients 2–4 
had increased leukocyte counts that 
were lymphocytic.
The diagnoses of the 10 
remaining patients were classified 
as miscodes because the written 
diagnoses in the charts did not 
mention lymphocytic meningitis. 
Two patients had central nervous 
system disease (Lyme encephalitis 
and tuberculosis meningitis) although 
an etiologic agent was confirmed that 
was not LCMV. Additional diagnoses 
mistakenly coded are shown in 
the Table.
Among the 4 patients identified 
as having clinical signs and symptoms 
of suspected LCMV infection in 
the Southwest and Southern Plains 
regions during fiscal years 2001–09, 
the average annual incidence rate was 
estimated to be 0.06 cases/100,000 
persons. In the same population, viral 
meningitis not otherwise specified was 
reported for 971 patients (incidence rate 
13.69 cases/100,000 persons/year). 
Unspecified causes of encephalitis, 
myelitis, or encephalomyelitis were 
diagnosed for 444 patients (incidence 
rate 6.26 cases/100,000 persons), and 
unspecified non-arthropod–borne 
viral diseases of the central nervous 
system or viral encephalitis not 
otherwise specified were diagnosed 
for 56 patients (incidence rate 0.78 
cases/100,000 persons).
Using a population-based analysis 
of diagnoses for patients who visited 
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